REFERENCES
Baldus, S. E.,
Hanisch, F. G.,
Schwonzen, M.,
Nakahara, Y.,
Iijima, H.,
Ogawa, T.,
Peter-Katalinic, J. and
Uhlenbruck, G. (
1992).
Monoclonal antibody SP-21 defines a sialosyl-Tn antigen expressed on carcinomas and K562 erythroleukemia cells.
Anticancer Research
12,
1935–1940.
Barchi, J. J. (
2000).
Emerging roles of carbohydrates and glycomimetics in anticancer drug design [Review].
Current Pharmaceutical Design
6,
485–501.
Barranco, S. C.,
Townsend, C. M. J.,
Casartelli, C.,
Macik, B. G.,
Burger, N. L.,
Boerwinkle, W. and
Gourley, W. K. (
1983).
Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach.
Cancer Research
43,
1703–1709.
Campbell, B. J.,
Finnie, I. A.,
Hounsell, E. F. and
Rhodes, J. M. (
1995).
Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Journal of Clinical Investigation
95,
571–576.
Cao, Y.,
Stosiek, P.,
Springer, G. F. and
Karsten, U. (
1996).
Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.
Histochemistry and Cell Biology
106,
197–207.
Cheever, A.,
Kuntz, R.,
Moore, J. and
Huang, T. (
1988).
Pathology of Schistosoma haematobium infection in the capuchin monkey (Cebus apella).
Transactions of the Royal Society of Tropical Medicine and Hygiene
82,
107–111.
Chitsulo, L.,
Engels, D.,
Montresor, A. and
Savioli, L. (
2000).
The global status of schistosomiasis and its control.
Acta Tropica
77,
41–51.
Cummings, R. D. and
Nyame, A. K. (
1999).
Schistosome glycoconjugates.
Biochimica et Biophysica Acta
1455,
363–374.
Dahlenborg, K.,
Hultman, L.,
Carlsson, R. and
Jansson, B. (
1997).
Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.
International Journal of Cancer
70,
63–71.
Eberl, M.,
Langermans, J. A.,
Vervenne, R. A.,
Nyame, A. K.,
Cummings, R. D.,
Thomas, A. W.,
Coulson, P. S. and
Wilson, R. A. (
2001).
Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive?
Journal of Infectious Diseases
183,
1238–1247.
Eble, J.,
Sauter, G.,
Epstein, J. and
Sesterhenn, I. (
2004)
World Health Organization. Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs.
IARC Press,
Lyon.
Fadden, A. J.,
Holt, O. J. and
Drickamer, K. (
2003).
Molecular characterization of the rat Kupffer cell glycoprotein receptor.
Glycobiology
13,
529–537.
Hanisch, F. G. and
Baldus, S. E. (
1997).
The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen.
Histology and Histopathology
12,
263–281.
Harris, J. R. and
Markl, J. (
1999).
Keyhole limpet hemocyanin (KLH): a biomedical review [Review].
Micron
30,
597–623.
Haslam, S. M.,
Coles, G. C.,
Morris, H. R. and
Dell, A. (
2000).
Structural characterization of the N-glycans of Dictyocaulus viviparus: discovery of the Lewis(x) structure in a nematode.
Glycobiology
10,
223–229.
Hicks, R. M.,
James, C. and
Webbe, G. (
1980).
Effect of Schistosomiasis haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in baboon.
British Journal of Cancer
42,
730–755.
Huang, H. H.,
Tsai, P. L. and
Khoo, K. H. (
2001).
Selective expression of different fucosylated epitopes on two distinct sets of Schistosoma mansoni cercarial O-glycans: identification of a novel core type and Lewis X structure.
Glycobiology
11,
395–406.
Jacobs, W.,
Deelder, A. and
Van Marck, E. (
1999).
Schistosomal granuloma modulation. II. Specific immunogenic carbohydrates can modulate schistosome-egg-antigen-induced hepatic granuloma formation.
Parasitology Research
85,
14–18.
Jurincic-Winkler, C. D.,
von der Kammer, H.,
Beuth, J.,
Scheit, K. H. and
Klippel, K. F. (
1996).
Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.
Anticancer Research
16,
2105–2110.
Kantelhardt, S. R.,
Wuhrer, M.,
Dennis, R. D.,
Doenhoff, M. J.,
Bickle, Q. and
Geyer, R. (
2002).
Fuc(alpha1−>3)GalNAc-: the major antigenic motif of Schistosoma mansoni glycolipids implicated in infection sera and keyhole-limpet haemocyanin cross-reactivity.
The Biochemical Journal
366,
217–223.
Langkilde, N. C.,
Wolf, H.,
Clausen, H. and
Orntoft, T. F. (
1992).
Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1–3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
Cancer Research
52,
5030–5036.
Linder, E.,
Thors, C. and
Lundin, L. (
1991).
Isolation of an SBA lectin-reactive glycoprotein (gp50) and its identification in Schistosoma mansoni larval and adult worm secretions.
Journal of Parasitology
77,
391–401.
MacLean, G. D. and
Longenecker, B. M. (
1991).
Clinical significance of the Thomsen-Friedenreich antigen.
Seminars in Cancer Biology
2,
433–439.
Mostafa, M. H.,
Sheweita, S. A. and
O'Connor, P. J. (
1999).
Relationship between schistosomiasis and bladder cancer.
Clinical Microbiology Reviews
12,
97–111.
Nyame, A. K.,
Lewis, F. A.,
Doughty, B. L.,
Correa-Oliveira, R. and
Cummings, R. D. (
2003).
Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention.
Experimental Parasitology
104,
1–13.
Polman, K.,
Stelma, F. F.,
Le Cessie, S.,
De Vlas, S. J.,
Falcao Ferreira, S. T.,
Talla, I.,
Deelder, A. M. and
Gryseels, B. (
2002).
Evaluation of the patterns of Schistosoma mansoni infection and re-infection in Senegal, from faecal egg counts and serum concentrations of circulating anodic antigen.
Annals of Tropical Medicine and Parasitology
96,
679–689.
Ragupathi, G. (
1996).
Carbohydrate antigens as targets for active specific immunotherapy.
Cancer Immunology and Immunotherapy
43,
152–157.
Samuel, J.,
Noujaim, A. A.,
MacLean, G. D.,
Suresh, M. R. and
Longenecker, B. M. (
1990).
Analysis of human tumor associated Thomsen-Friedenreich antigen.
Cancer Research
50,
4801–4808.
Sell, S. (
1990).
Cancer-associated carbohydrates identified by monoclonal antibodies.
Human Pathology
21,
1003–1019.
Shigeoka, H.,
Karsten, U.,
Okuno, K. and
Yasutomi, M. (
1999).
Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody.
Tumour Biology
20,
139–146.
Sobin, L. H. and
Wittekind, C.h. (
2002).
TNM Classification of Malignant Tumours,
Wiley-Liss,
New York.
Springer, G. F. (
1997).
Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy.
Journal of Molecular Medicine
75,
594–602.
Thors, C. and
Linder, E. (
1998).
Cross-reacting antibodies against keyhole limpet haemocyanin may interfere with the diagnostics of acute schistosomiasis.
Parasite Immunology
20,
489–496.
Thors, C. and
Linder, E. (
2003).
Localization and identification of Schistosoma mansoni/KLH-crossreactive components in infected mice.
Journal of Histochemistry and Cytochemistry
51,
1367–1374.
van Dam, G. J.,
Claas, F. H.,
Yazdanbakhsh, M.,
Kruize, Y. C.,
van Keulen, A. C.,
Ferreira, S. T.,
Rotmans, J. P. and
Deelder, A. M. (
1996).
Schistosoma mansoni excretory circulating cathodic antigen shares Lewis-x epitopes with a human granulocyte surface antigen and evokes host antibodies mediating complement-dependent lysis of granulocytes.
Blood
88,
4246–4251.
WORLD HEALTH ORGANIZATION (
1994).
Evaluation of carcinogenic risk to humans. Schistosomes, liver flukes and Helicobacter pylori.
IARC Monograph
61,
45–119.
Wuhrer, M.,
Dennis, R. D.,
Doenhoff, M. J.,
Lochnit, G. and
Geyer, R. (
2000).
Schistosoma mansoni cercarial glycolipids are dominated by Lewis X and pseudo-Lewis Y structures.
Glycobiology
10,
89–101.
Yu, L. G.,
Jansson, B.,
Fernig, D. G.,
Milton, J. D.,
Smith, J. A.,
Gerasimenko, O. V.,
Jones, M. and
Rhodes, J. M. (
1997).
Stimulation of proliferation in human colon cancer cells by human monoclonal antibodies against the TF antigen (galactose beta1-3 N-acetyl-galactosamine).
International Journal of Cancer
73,
424–431.
Zhang, S.,
Zhang, H. S.,
Reuter, V. E.,
Slovin, S. F.,
Scher, H. I. and
Livingston, P. O. (
1998).
Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
Clinical Cancer Research
4,
295–302.
